Matches 1 - 50 out of 257 1 2 3 4 5 6 >


Match Document Document Title
US20130096052 PROCALCITONIN FOR THE DIAGNOSIS OF BACTERIAL INFECTIONS AND GUIDANCE OF ANTIBIOTIC TREATMENT IN PATIENTS WITH NON-SPECIFIC COMPLAINTS  
The present invention relates to the determination of the level of marker peptides in a sample derived from a bodily fluid of a subject presenting with non-specific complaints.
US20140066365 USE OF CALIXARENES ASSOCIATED WITH AN ANTIBIOTIC IN THE TREATMENT OF BACTERIAL INFECTIONS  
A product comprising at least one given antibiotic and a calixarene for use as medicament.
US20100112091 USE OF RAMOPLANIN TO TREAT DISEASES ASSOCIATED WITH THE USE OF ANTIBIOTICS  
The invention features a method of treating or preventing a disease associated with the use of antibiotics in a patient in need thereof by administering to the patient ramoplanin in an amount and...
US20120035097 METHODS OF TREATING BACTERIAL INFECTIONS USING ORITAVANCIN  
The present invention is directed to methods of treating a bacterial infection in a subject through the administration of a therapeutically effective amount of a glycopeptide antibiotic to a...
US20150110767 METHODS FOR TREATING LUNG INFECTIONS AND INFLAMMATION  
Methods of treating, reducing, or preventing lung infections or lung inflammation include identifying a patient in need of treatment and administering a therapeutically effective amount of at...
US20140323391 BIOMARKERS FOR THE MOLECULAR CLASSIFICATION OF BACTERIAL INFECTION  
Disclosed herein are biomarkers useful for identifying and/or classifying bacterial infections in a subject.
US20140066364 CYANOACRYLATE TISSUE ADHESIVES  
A tissue adhesive including cyanoacrylate and polyethylene glycol (PEG), wherein the PEG remains a polyether and wherein the tissue adhesive is bioabsorbable. A tissue adhesive including...
US20110224723 CYANOACRYLATE TISSUE ADHESIVES  
A tissue adhesive including cyanoacrylate and polyethylene glycol (PEG), wherein the PEG remains a polyether and wherein the tissue adhesive is bioabsorbable. A tissue adhesive including...
US20150133366 COMPOSITIONS AND METHODS FOR TREATING CLOSTRIDIUM INFECTION AND PREVENTING RECURRENCE OF INFECTION  
C. difficile infection (CDI) is the most common cause of antibiotic-associated diarrhea. Unfortunately, antibiotic therapy remains as the standard treatment for this antibiotic-induced disease and...
US20140100157 METHOD OF INHIBITING CLOSTRIDIUM DIFFICILE BY ADMINISTRATION OF ORITAVANCIN  
Glycopeptide antibiotics, such as oritavancin, demonstrate significant activity against both a vegetative form of C. difficile and C. difficile spores. Methods for the treatment, prophylaxis and...
US20110144003 MAINTENANCE THERAPY REGIME/REGIMEN FOR THE TREATMENT OF ACNE  
A novel maintenance therapy regime/regimen for the treatment of acne related diseases includes administering an oral antibiotic with a topical fixed-dose combination of a retinoid, such as...
US20110294726 ANTIBIOTIC THERAPY TO REDUCE THE LIKELIHOOD OF DEVELOPING POST-INFECTIOUS IRRITABLE BOWEL SYNDROME  
The present invention provides for methods of preventing IBS, preventing long term irregular bowel pattern, reducing the likelihood of developing or having IBS, reducing the likelihood of...
US20120202737 New bacitracin antibiotics  
The invention concerns new Bacitracin compounds containing methylene-isoleucine.
US20120321596 KIT FOR ADHERING BIOLOGICAL HARD TISSUES  
A kit for bonding to biological hard tissues, containing a phosphorylated polysaccharide, a polyvalent metal salt other than phosphates, and a solvent. The adhesive composition for biological hard...
US20110178001 PHOSPHONATED RIFAMYCINS AND USES THEREOF FOR THE PREVENTION AND TREATMENT OF BONE AND JOINT INFECTIONS  
The present invention relates to phosphonated Rifamycins, and methods of making and using such compounds. These compounds are useful as antibiotics for prophylaxis and/or the treatment of bone and...
US20130129695 METHODS FOR TREATING OR INHIBITING INFECTION BY CLOSTRIDIUM DIFFICILE  
The invention provides methods for treating or inhibiting infection by Clostridium difficile in a subject in need of such treatment, comprising administering an effective amount of a compound...
US20130109617 SUBSTITUTED TETRACYCLINE COMPOUNDS FOR TREATMENT OF BACILLUS ANTHRACIS INFECTIONS  
Methods and compositions for the treatment of Bacillus anthracis infections are described.
US20150224129 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE PROPHYLACTIC TREATMENT OF BACTERIAL SUPERINFECTIONS POST-INFLUENZA WITH INVARIANT NKT CELL AGONISTS  
The present invention relates to methods and pharmaceutical compositions for the prophylactic treatment of bacterial superinfections post-influenza with iNKT cell agonists.
US20140050777 Liposomal Formulations of Polymyxin and Uses Thereof  
The present invention provides novel liposomal formulations of polymyxin B and pharmaceutical compositions thereof useful for the treatment of bacterial infections. The liposomal formulation...
US20140294925 FORMULATIONS COMBINING RAMOPLANIN AND RHAMNOLIPIDS FOR COMBATING BACTERIAL INFECTION  
Provided herein are methods of treating a superbug infection in a subject that include administering to the subject a therapeutically effective dose of ramoplanin in combination with a...
US20110124551 FORMULATIONS OF DAPTOMYCIN  
Long term storage stable daptomycin-containing compositions are disclosed. The compositions include a pharmacologically acceptable fluid including daptomycin or a pharmaceutically acceptable salt...
US20140256617 In Situ Forming Hydrogel and Method Using Same  
A hydrogel (I), comprising a polymer backbone wherein an aqueous solution of the hydrogel comprises a first lower critical solution temperature, and wherein the hydrogel is configured to be...
US20130137630 FORMULATIONS FOR INFUSION OF TYPE B LANTIBIOTICS  
Described is a A liquid colloidal pharmaceutical formulation of a type B lantibiotic for infusion or direct injection comprising a type B lantibiotic or a salt thereof, an isotonic aqueous...
US20140356457 NOVEL MEANS AND METHODS FOR THE TREATMENT OF HEARING LOSS AND PHANTOM HEARING  
This invention relates to a method of identifying a modulator of an NADPH oxidase, whereby said modulator is suitable as a lead compound and/or as a medicament for the treatment and/or prevention...
US20120141467 Ascorbic acid to treat chronic obstructive lung diseases and non-Hodgkin's lymphoma  
Provided herein is a method for treating a tracheo-bronchial-alveolar tract disease in a subject in need thereof, the method comprising the step of administering to a subject in need of such...
US20140171357 VANCOMYCIN DERIVATIVES  
The invention features vancomycin class compounds modified to be suitable for oral delivery or to possess increased antimicrobial potency, formulations for the oral administration of vancomycin...
US20150017099 DIAGNOSIS AND TREATMENT FOR RESPIRATORY TRACT DISEASES  
The invention provides methods and compositions for the diagnosis, prognosis and treatment of respiratory tract diseases. Specifically, the invention provides diagnosis, prognosis and treatment of...
US20130171252 Formulation Comprising a Type B Lantibiotic  
Described is a pharmaceutical formulation of a capsule for oral delivery of a type B lantibiotic to the stomach comprising a hard gelatine, HPMC or starch capsule, and a type B lantibiotic of...
US20110294725 Use of predissolved pristinamycin-type and polyether ionophore type antimicrobial agents in the production of ethanol  
A method of controlling microorganisms such as lactobacilli metabolism in mash in an ethanol production facility includes adding to the mash an effective amount to control such microorganisms of...
US20140371135 HIGH PURITY LIPOPEPTIDES  
The invention discloses highly purified daptomycin and to pharmaceutical compositions comprising this compound. The invention discloses a method of purifying daptomycin comprising the sequential...
US20110207658 High Purity Lipopeptides  
The invention discloses highly purified daptomycin and to pharmaceutical compositions comprising this compound. The invention discloses a method of purifying daptomycin comprising the sequential...
US20110160125 METHOD AND CULTURE MEDIUM FOR ENHANCED DETECTION OF MYCOBACTERIUM  
The present invention relates to an improved culture medium and method for the enhanced growth and detection of Mycobacterium growth. The invention further relates to an improved mycobacterial...
US20150056160 CHEMICALLY INDUCED INTRACELLULAR HYPERTHERMIA  
An invention relating to therapeutic pharmacological agents and methods to chemically induce intracellular hyperthermia and/or free radicals for the diagnosis and treatment of infections,...
US20120040033 Anti-infective mangrove extract against viruses, bacteria and fungi  
The current invention discloses drug formulations of anti-infective mangrove extracts and their ability to block the reproductive capabilities of viruses, funguses, bacteria and tumors. Mangrove...
US20110020216 SCAFFOLDS FOR CELL COLLECTION OR ELIMINATION  
A device that includes a scaffold composition and a bioactive composition with the bioactive composition being incorporated therein or thereon, or diffusing from the scaffold composition such that...
US20120277145 Compounds  
The present invention pertains generally to certain compounds of the deoxyactagardine A and B type. Such compounds are suitable for use in the treatment of microbial infections, for example...
US20150192593 BIOMARKERS FOR DIAGNOSING AND/OR MONITORING TUBERCULOSIS  
The invention relates to biomarkers for diagnosing and/or monitoring tuberculosisin both immunocompetent and immunocompromised individuals, monitoring the responses of individuals to...
US20130274174 THERAPEUTIC COMBINATION OF DAPTOMYCIN AND PROTEIN SYNTHESIS INHIBITOR ANTIBIOTIC, AND METHODS OF USE  
A therapeutic combination comprises an antibacterially effective amount of daptomycin, and an amount of protein synthesis inhibitor antibiotic effective to prevent the development of daptomycin...
US20130102523 THERAPEUTIC COMBINATION OF DAPTOMYCIN AND PROTEIN SYNTHESIS INHIBITOR ANTIBIOTIC, AND METHODS OF USE  
A therapeutic combination comprises an antibacterially effective amount of daptomycin, and an amount of protein synthesis inhibitor antibiotic effective to prevent the development of daptomycin...
US20110053832 NATURAL ANTIMICROBIAL COMPOSITION  
Natural antimicrobials for foods, such as salad dressings and dairy products to target a broad spectrum of food emulsion spoilage microorganisms such as lactic acid bacteria and fungi such as...
US20110039764 THERAPEUTIC COMPOSITION FOR BONE INFECTIOUS DISEASE  
A biodegradable composition containing an antibiotic or a physiologically active substance for use in surgical treatment of infection. A highly safe and biocompatible composition showing...
US20120196791 COMBINATION THERAPIES USING ANTIBACTERIAL AMINOGLYCOSIDE COMPOUNDS  
Methods for treating a bacterial infection in a mammal in need thereof, and compositions related thereto, are disclosed, the methods comprising administering to the mammal an effective amount of...
US20110257078 ANTIBACTERIAL COMBINATION THERAPY FOR THE TREATMENT OF GRAM POSITIVE BACTERIAL INFECTIONS  
There is described a composition comprising a therapeutically active imidazole, and derivatives thereof, and an agent active on a bacterial cell surface selected from the group consisting of one...
US20060093597 Methods of treating involuntary facial spasms and facial wrinkles  
The invention describes antibiotics, muscle relaxants and plant extracts that have neuromuscular blockade effects as well as methods of use thereof. These compounds can be used in the same...
US20140296134 METHODS AND USES FOR METABOLIC PROFILING FOR CLOSTRIDIUM DIFFICILE INFECTION  
Embodiments include methods for generating a metabolite profile of a stool sample and methods of assessing the status of a subject using the metabolic profile derived from a stool sample.
US20110190199 Combination Therapy for Tuberculosis  
The present invention relates to methods of treating tuberculosis, including multi-drug resistant varieties and latent tuberculosis. More particularly, the present invention relates to a method of...
US20130252883 Macrocycles and Their Uses  
The present application describes a method of treating a bacterial infection comprising administering to a subject in need thereof a pharmaceutically acceptable amount of a defined macrocycle...
US20140256616 MODIFIED GREEN TEA POLYPHENOL FORMULATIONS  
Modified green tea polyphenols and methods of their use are provided. One aspect provides compounds and compositions containing green tea polyphenols with one on more ester-linked fatty acids.
US20100113333 PHOSPHONATED GLYCOPEPTIDE AND LIPOGLYCOPEPTIDE ANTIBIOTICS AND USES THEREOF FOR THE PREVENTION AND TREATMENT OF BONE AND JOINT INFECTIONS  
The present invention is directed to antimicrobial compounds which have an affinity for binding bones. More particularly, the invention is directed to phosphonated derivatives of glycopeptide or...
US20070128124 Aerosolized capreomycin for inhibition of pulmonary tuberculosis  
The invention provides systems, methods, and compositions for the aerosolized administration of capreomycin to persons in need thereof. Administration of capreomycin by aerosol can be used to...

Matches 1 - 50 out of 257 1 2 3 4 5 6 >